4.7 Article

A Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Prediction Model From Standard Laboratory Tests

期刊

CLINICAL INFECTIOUS DISEASES
卷 73, 期 9, 页码 E2901-E2907

出版社

OXFORD UNIV PRESS INC
DOI: 10.1093/cid/ciaa1175

关键词

machine learning; human coronavirus; polymerase chain reaction; viral pneumonia

资金

  1. Bitscopic's RD budget
  2. Department of Veterans Affairs

向作者/读者索取更多资源

This study utilized a machine learning model to analyze the correlation between SARS-CoV-2 test results and 20 routine laboratory tests, achieving a high level of accuracy in predicting the test results within a large cohort of 75,991 patients.
Background. With the limited availability of testing for the presence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus and concerns surrounding the accuracy of existing methods, other means of identifying patients are urgently needed. Previous studies showing a correlation between certain laboratory tests and diagnosis suggest an alternative method based on an ensemble of tests. Methods. We have trained a machine learning model to analyze the correlation between SARS-CoV-2 test results and 20 routine laboratory tests collected within a 2-day period around the SARS-CoV-2 test date. We used the model to compare SARS-CoV-2 positive and negative patients. Results. In a cohort of 75 991 veteran inpatients and outpatients who tested for SARS-CoV-2 in the months of March through July 2020, 7335 of whom were positive by reverse transcription polymerase chain reaction (RT-PCR) or antigen testing, and who had at least 15 of 20 lab results within the window period, our model predicted the results of the SARS-CoV-2 test with a specificity of 86.8%, a sensitivity of 82.4%, and an overall accuracy of 86.4% (with a 95% confidence interval of [86.0%, 86.9%]). Conclusions. Although molecular-based and antibody tests remain the reference standard method for confirming a SARSCoV-2 diagnosis, their clinical sensitivity is not well known. The model described herein may provide a complementary method of determining SARS-CoV-2 infection status, based on a fully independent set of indicators, that can help confirm results from other tests as well as identify positive cases missed by molecular testing.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据